Literature DB >> 6134847

Transcription from the BamHI J fragment of herpes simplex virus type 1 (KOS).

J L Betz, T M Hill, L I Pizer, M L Peake, J R Sadler.   

Abstract

RNA transfer experiments (Northern analyses) were used to localize polyadenylated mRNA species made after herpes simplex virus type 1 infection to EcoRI and BamHI fragments and subfragments from the short unique region of the herpes simplex virus type 1 (KOS) genome. Three predominant early mRNAs of 2.5, 1.3, and 0.9 kilobases map in the BamHI J fragment. A detailed restriction map of the BamHI J fragment was constructed.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6134847      PMCID： PMC255239     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  28 in total

1.  Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid.

Authors:  A C Chang; S N Cohen
Journal:  J Bacteriol       Date:  1978-06       Impact factor: 3.490

2.  Recombinants between herpes simplex virus types 1 and 2: analyses of genome structures and expression of immediate early polypeptides.

Authors:  V G Preston; A J Davison; H S Marsden; M C Timbury; J H Subak-Sharpe; N M Wilkie
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

3.  Physical mapping of herpes simplex virus-induced polypeptides.

Authors:  H S Marsden; N D Stow; V G Preston; M C Timbury; N M Wilkie
Journal:  J Virol       Date:  1978-11       Impact factor: 5.103

4.  Temporal regulation of herpes simplex virus type 1 transcription: location of transcripts on the viral genome.

Authors:  J B Clements; R J Watson; N M Wilkie
Journal:  Cell       Date:  1977-09       Impact factor: 41.582

5.  Anatomy of herpes simplex virus (HSV) DNA. X. Mapping of viral genes by analysis of polypeptides and functions specified by HSV-1 X HSV-2 recombinants.

Authors:  L S Morse; L Pereira; B Roizman; P A Schaffer
Journal:  J Virol       Date:  1978-05       Impact factor: 5.103

6.  Labeling deoxyribonucleic acid to high specific activity in vitro by nick translation with DNA polymerase I.

Authors:  P W Rigby; M Dieckmann; C Rhodes; P Berg
Journal:  J Mol Biol       Date:  1977-06-15       Impact factor: 5.469

7.  Construction and characterization of new cloning vehicles. III. Derivatives of plasmid pBR322 carrying unique Eco RI sites for selection of Eco RI generated recombinant DNA molecules.

Authors:  F Bolivar
Journal:  Gene       Date:  1978-10       Impact factor: 3.688

8.  pBR322 restriction map derived from the DNA sequence: accurate DNA size markers up to 4361 nucleotide pairs long.

Authors:  J G Sutcliffe
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

9.  Cloning of chemically synthesized lactose operators. II. EcoRI-linkered operators.

Authors:  J R Sadler; J L Betz; M Tecklenburg; D V Goeddel; D G Yansura; M H Caruthers
Journal:  Gene       Date:  1978-05       Impact factor: 3.688

10.  Construction and characterization of new cloning vehicles. I. Ampicillin-resistant derivatives of the plasmid pMB9.

Authors:  F Bolivar; R L Rodriguez; M C Betlach; H W Boyer
Journal:  Gene       Date:  1977       Impact factor: 3.688
View more
  3 in total

1.  RNAs transcribed from a 3.6-kilobase SmaI fragment of the short unique region of the herpes simplex virus type 1 genome.

Authors:  K Ikura; J L Betz; J R Sadler; L I Pizer
Journal:  J Virol       Date:  1983-11       Impact factor: 5.103

2.  ICP4-binding sites in the promoter and coding regions of the herpes simplex virus gD gene contribute to activation of in vitro transcription by ICP4.

Authors:  D G Tedder; R D Everett; K W Wilcox; P Beard; L I Pizer
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

3.  The ICP4 binding sites in the herpes simplex virus type 1 glycoprotein D (gD) promoter are not essential for efficient gD transcription during virus infection.

Authors:  J R Smiley; D C Johnson; L I Pizer; R D Everett
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.